GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TheraCryf PLC (LSE:TCF) » Definitions » Float Percentage Of Total Shares Outstanding

TheraCryf (LSE:TCF) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 15, 2025)


View and export this data going back to 2015. Start your Free Trial

What is TheraCryf Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, TheraCryf's float shares is 0.00 Mil. TheraCryf's total shares outstanding is 2,129.62 Mil. TheraCryf's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, TheraCryf's Insider Ownership is 2.22%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, TheraCryf's Institutional Ownership is 15.71%.

TheraCryf Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

TheraCryf's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/2,129.62
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TheraCryf Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TheraCryf PLC (LSE:TCF) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
LSE:GENF LSE:APTA LSE:BSFA LSE:CIZ LSE:CRTX LSE:ROQ AQSE:INC LSE:FAB LSE:NFX LSE:HEMO VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Congleton Road, Alderley Park, Nether Alderley, Cheshire, GBR, SK10 4TG
Website
https://www.evgen.com
TheraCryf PLC is a clinical-stage biotechnology company focused on profitable segments in oncology and neuropsychiatry. The company's lead clinical asset, SFX-01 is a patented form of delivering sulforaphane, which could be used in the treatment of a number of cancers, neurodevelopmental disorders, and other diseases.